Metraipolis › archive › dc_c47fdf978800

Preclinical research of dihydromyricetin for fibrotic diseases — Europe PMC PMID:41415577

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41415577
DOI
10.3389/fphar.2025.1691796
License (as archived)
solo-consultazione
Archived
2026-11-07T23:40:30.358Z
SHA-256 of the archived text
69b57b38a7b8a952e472f46827ee8ee739e8f8c4380bc318692ad85a47e0b115
Stable URL of this page
https://metraipolis.com/documento/dc_c47fdf978800

How to cite

Preclinical research of dihydromyricetin for fibrotic diseases — Europe PMC PMID:41415577 — Europe PMC (en), https://europepmc.org/article/MED/41415577 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c47fdf978800 (Metraipolis archive dc_c47fdf978800, sha256 69b57b38a7b8a952e472f46827ee8ee739e8f8c4380bc318692ad85a47e0b115)
BibTeX
@misc{dcc47fdf978800,
  title = {Preclinical research of dihydromyricetin for fibrotic diseases — Europe PMC PMID:41415577},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41415577},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c47fdf978800; sha256 69b57b38a7b8a952e472f46827ee8ee739e8f8c4380bc318692ad85a47e0b115},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41415577. Agents can read the archived copy with the MCP tool read_document.